tiprankstipranks
Trending News
More News >
Esperion Therapeutics (ESPR)
:ESPR
Advertisement

Esperion (ESPR) Revenue

Compare
1,629 Followers

Esperion Revenue

Esperion had a revenue of 87.31M in the quarter ending Sep 30, 2025, with 5.98%. This bring the company's revenue in the last twelve months to 303.80M, Decreased 13.31%. In the fiscal year ending Dec 31, 2024, Esperion had annual revenue of 332.31M with 185.66% growth.
Revenue (ttm)
303.80M
Revenue Growth
2.83%
P/S Ratio
2.84
Revenue/Employee
$1,093,138
Employees
304
Market Cap
$944.30M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
332.31M215.98M+285.66%
Dec 31, 2023
116.33M40.86M+154.14%
Dec 31, 2022
75.47M-2.97M+96.21%
Dec 31, 2021
78.45M-149.10M+34.48%
Dec 31, 2020
227.55M79.18M+153.37%
Dec 31, 2019
148.36M-36.11M+80.43%
Dec 31, 2018
184.47M-18,447,400,000.00%
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis